Formyl peptide receptor-like 1–mediated endogenous TRAIL gene expression with tumoricidal activity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-07-0286PMID 17938258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II

  2007cited by this paper
• Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.

  2005influential reference
• CpG‐containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1–42 peptide by up‐regulating the expression of the G‐protein‐coupled receptor mFPR2

  2005cited by this paper
• A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death*

  2005cited by this paper
• Oral adeno‐associated virus‐sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice

  2005cited by this paper
• Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

  2005cited by this paper
• Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand*

  2005cited by this paper
• Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma.

  2005cited by this paper
• Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Response to Influenza Virus Infection in Mice

  2005cited by this paper
• Following a TRAIL: Update on a ligand and its five receptors

  2004cited by this paper
• Blocking Programmed Death-1 Ligand-PD-1 Interactions by Local Gene Therapy Results in Enhancement of Antitumor Effect of Secondary Lymphoid Tissue Chemokine1

  2004cited by this paper
• NF-κB-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation*

  2004cited by this paper
• Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice

  2003cited by this paper
• Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.

  2003influential reference
• [The primary study on a novel protein binding to the death domain of the death receptor 4].

  2002cited by this paper
• TNF ligands and receptors in autoimmunity: an update.

  2002cited by this paper
• Formyl-peptide receptors revisited.

  2002cited by this paper
• Characterization of the in vivo function of TNF‐α‐related apoptosis‐inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene‐deficient mice

  2002cited by this paper
• Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

  2001cited by this paper
• The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

  2001cited by this paper
• Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression.

  2001cited by this paper
• Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

  2001cited by this paper
• Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.

  2001cited by this paper
• Pleiotropic roles of formyl peptide receptors.

  2001cited by this paper
• Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

  2001cited by this paper
• Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2

  2001cited by this paper
• Amyloid β42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1

  2001cited by this paper
• β Amyloid peptide (Aβ42) is internalized via the G‐protein‐coupled receptor FPRL1 and forms fibrillar aggregates in macrophages1

  2001cited by this paper
• Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression1

  2001cited by this paper
• Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

  2000cited by this paper
• Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

  2000cited by this paper
• Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

  2000cited by this paper
• N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes.

  2000cited by this paper
• Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis1

  2000cited by this paper
• Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.

  1999cited by this paper
• A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.

  1999cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper

• Biased perspectives on formyl peptide receptors.

  2019cites this paper
• Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis

  2018cites this paper
• Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

  2014cites this paper
• Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists

  2013cites this paper
• Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand

  2013cites this paper
• On the cytokines produced by human neutrophils in tumors.

  2013cites this paper
• Mannan-modified Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice

  2012cites this paper
• E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma

  2011cites this paper
• NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.

  2011cites this paper
• Role of endogenous Annexin-A1 in the regulation of thymocyte positive and negative selection

  2010influential citation
• Identification of Novel Small-Molecule Agonists for Human Formyl Peptide Receptors and Pharmacophore Models of Their Recognition

  2010cites this paper
• Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway.

  2010cites this paper
• The Current State of Head and Neck Cancer Gene Therapy

  2009cites this paper
• Duplex high‐throughput flow cytometry screen identifies two novel formylpeptide receptor family probes

  2009cites this paper
• Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

  2009cites this paper
• International progress in cancer gene therapy

  2008cites this paper